Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Date:11/14/2013

>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.

For further information, please visit www.delmarpharma.com.


'/>"/>
SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 20, 2015 ... announced the addition of the "Cardiometabolic Drug ... Afrezza,s discounted pricing is in line with ... critical to the product,s commercial appeal. However, contraindications, ... Afrezza from gaining a sizeable share of the ...
(Date:7/27/2015)... , July 27, 2015  Linear accelerators used ... machines, requiring not only adequate space for the ... their operation. Inherent to the size and complexity ... accelerator or the addition of a new vault ... operations risks interruption of patient treatment: with potential ...
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/65t478/gprotein_coupled ) has ... Receptors Market: Global Industry Analysis, Size, Share, Growth, ... to their offering. The global ... assay type, therapeutic area, and geography. Based on ... into six major segments: cAMP assays, calcium level ...
Breaking Medicine Technology:Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3Accelerating the Design Process for Cancer Treatment Centers 2Accelerating the Design Process for Cancer Treatment Centers 3G-Protein Coupled Receptors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 2
... Phase II trial of a single,intraoperative administration of ... in the first 8 to 24 hours following,surgery, ... treatment.,The results of the multicenter, randomized, double-blind study ... Assembly in Anesthesiology in New York,City today, by ...
... Canada, Dec. 12 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... that identifies, develops and commercializes differentiated products for ... CIMYM BioSciences Inc. received a milestone payment from ... of the recent marketing approval of nimotuzumab in ...
Cached Medicine Technology:Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA) 4YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 2YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 3YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia 4
(Date:7/27/2015)... ... July 27, 2015 , ... The Maricopa Community Colleges ... the foster care system to get into and complete college. , The “Bridging ... at an event today with partners from across the valley. , The initiative advisory ...
(Date:7/27/2015)... NY (PRWEB) , ... July 27, 2015 , ... ... tour. He will be performing for one additional night at each of his ... promo/coupon code DAVID-GILMOUR-2016 for added savings. , David Gilmour’s 2016 North America tour dates: ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... professional and in-depth research report. The report provides basic information such as ... etc. This report covers the global (US, Europe, Japan etc) industry analysis ...
(Date:7/27/2015)... ... July 27, 2015 , ... With a new charity program ... to support its mission of reducing the number of deaths and injuries occurring from ... and their families. PursuitSAFETY works with the police to find better and safer ...
(Date:7/27/2015)... ... July 27, 2015 , ... Throughout its 20 year history, Doctors on ... working on a lien basis. As the personal injury and medical industries have ... chiropractors, to orthopedists, to pain management physicians, to psychologists and more. And while ...
Breaking Medicine News(10 mins):Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2
... students finds 20% took substances without approval , , MONDAY, ... non-medical use of frequently abused prescription drugs increases the ... study. , Researcher Sean Esteban McCabe asked 3,639 college ... non-prescribed use of four classes of prescription drugs -- ...
... clear association, but no such link for depression , , MONDAY, ... help bring on a stroke may have merit, British researchers ... groups according to how severe their stress is, someone in ... 40 percent increased risk of stroke than someone in the ...
... New York physicians,facing a potential surcharge in malpractice insurance ... an expected one thousand New,York physicians will be in ... Tuesday, March 4th where they will be addressed by ... Capitol steps by 12:30 p.m. to demand,justice and malpractice ...
... BIRMINGHAM, Ala., March 3 Emageon Inc.,(Nasdaq: ... technology,systems for hospitals, healthcare networks and imaging facilities ... will present at the,Raymond James 29th Annual Institutional ... Regency Grand Cypress, Orlando, Florida. Emageon will,present on ...
... ... Today 5,000 Nurses at 11 ... In an atmosphere that nurses,describe as attempted "intimidation" from Sutter ... authorize,their bargaining teams to strike the hospital chain for up to ...
... Rally Behind California Assembly Bills Protecting State,s,Elderly ... SACRAMENTO, Calif., March 3 California,seniors ... Senior Living have,teamed up with advocates and ... increases, and to address serious problems with ...
Cached Medicine News:Health News:Non-Medical Use of Prescriptions Linked to Drug Abuse Risk 2Health News:Stress Can Help Trigger Stroke 2Health News:Attention New York: Please Don't Get Sick on March 4th, Your Doctor Will be in Albany for Malpractice Insurance Reform 2Health News:In Face of Hostile Bargaining and Intimidation by Management, Mills-Peninsula to Vote to Authorize Strike 2Health News:In Face of Hostile Bargaining and Intimidation by Management, Mills-Peninsula to Vote to Authorize Strike 3Health News:'Atria Bills' Get Support From Assisted Living Residents, Family Members, Senior Groups 2
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Microbiology QC Slides come with one or two droplets of an air-dried and methanol-fixed microorganism, or a single smear containing a designated microorganism population....
Each slide contains a high yield of concentrated C. parvum oocysts within the positive control well. A negative control well is also included....
... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
Medicine Products: